Portal Solutions

05/15/2017 -
No One Chooses Diabetes
Patients with diabetes often find that people who should know better may display shocking ignorance of the causes of diabetes and equally shocking lack of compassion for those who have to deal with the many issues and stresses caused by the disease. It is therefore deeply disturbing to learn that Mr. Mick Mulvaney, the Director of the Office of Management and Budget, a member of the Cabinet of Donald Trump, stated that patients with type 2 diabetes have brought the condition on themselves and are less deserving of being covered by medical insurance as a result.

He is wrong on the science, and he is wrong on the policy, and I would encourage all those with diabetes and their families and loved ones to call their congressional representatives, both those in the House of Representatives and in the US Senate and make clear that people with diabetes should not be allowed to be forced into high risk insurance pools, which have never worked well. The present law protects all patients, both those with diabetes, as well as those with other chronic illnesses by virtue of allowing pre-existing conditions to be covered, and this essential patient protection should not be waived so insurers will be allowed to sell less useful insurance at lower rates.

Richard Hellman, MD, FACP, FACE
Clinical Professor of Medicine, University of Missouri-Kansas City School of Medicine
Associate Program Director, Endocrine Fellowship (UMKC)
Member, Editorial Board, Diabetes Care
Past President, American Association of Clinical Endocrinologists
Medical Director, Heart of America Diabetes Research Foundation

04/20/2017 -
We are pleased to announce that Dr. Hellman was recently selected to receive his third "Distinguished Reviewer" award from the American Diabetes Association (ADA) and the Editorial Board of Diabetes Care. Each year, only 10 reviewers, from the thousands of national and international reviewers that they utilize, are chosen to receive this award. For the third year in a row, Dr. Hellman was chosen to receive this honor, which reveals their trust and confidence in his level of knowledge, judgment, and care taken in assessing which scientific papers are valid and important enough to be published in Diabetes Care.

Diabetes Care, published by the American Diabetes Association, is considered by many experts to be the leading clinical diabetes journal in the world. The journal focuses on increasing healthcare practitioners' knowledge, stimulating research and promoting better diabetes management, and in order for new advances in the science of diabetes care to be accepted, there first needs to be research published in a leading scientific journal such as this. The editors of Diabetes Care take great care that these scientific articles are first judged by their manuscript reviewers, a carefully selected worldwide panel of diabetes experts. It is considered a great honor to be one of their reviewers.

03/30/2017 - Continuous Glucose Monitoring now covered by Medicare
Continuous Glucose Monitoring (CGM) is now covered by Medicare - a win for Medicare patients with diabetes who have difficult-to-control diabetes. On March 24, 2017, Medicare announced that it will pay for a CGM device, the Dexcom G5 mobile CGM. Dr. Hellman has been one of the leaders in the fight to make this new technology affordable for our Medicare patients with diabetes. Last year, the Chief Medical Officer of the Centers for Medicare & Medicaid Services (CMS) invited him to meet and discuss how to improve the quality of care of patients with diabetes. During that meeting, Dr. Hellman emphasized the need to provide CGM to those patients with diabetes who, despite frequent glucose monitoring and multiple insulin injections per day, have difficulty controlling their diabetes. Dr. Hellman states that this victory would not have happened without the help of many groups, most notably the American Diabetes Association, all of whom worked together on behalf of our patients. Not every patient with diabetes will need this device, but we will now begin reaching out to many of our patients who will be eligible for the CGM device and who will benefit from the continuous protection a CGM will offer. Please contact our office if you are interested, particularly if you have been having severe hypoglycemia. Although expensive, CGM can be lifesaving and we have been using it for many years, and now, thankfully, it can be afforded by many more patients who need this technology.

01/13/2017 - We're live on twitter now!

10/13/2016 - Nurse Practitioner week is fast approaching and we'd like to thank our three NP's, Cheryl Ann Parsons, FNP-C, Duyen Nguyen, APRN-C and Debra McConville, ANP-BC, CDE! They've helped so many of our patients and we are very grateful for the high grade of care they've provided. Visit our site to see more and thank you again Cheryl, Duyen and Debra! http://www.nkcendo.com/practitioners.html

09/16/2016 - We'd like to congratulate our Practice Administrator Judy Lessenden, MHSA, CMPE on her 16 years of service with us! Her ability to keep our practice running smoothly has allowed us to keep patients happy and healthy. Thank you Judy!

07/08/2016 - Keep your blood sugar in check!

07/05/2016 - Congratulations to Dr. Howard Rosen on his 27th anniversary with Hellman & Rosen Endocrine Associates!

04/24/2016 - We are proud to announce that Dr. Hellman was recently selected to receive his second "Distinguished Reviewer" award from the American Diabetes Association (ADA) and the Editorial Board of Diabetes Care. Each year, from the thousands of national and international reviewers that they utilize, they choose 10 manuscript reviewers worldwide to receive this award. This is the second year in a row that Dr. Hellman has received this award, reflecting their trust and confidence in his level of knowledge, judgment, and care taken in determining which scientific papers are valid and important enough to be published in Diabetes Care.

Diabetes Care, published by the American Diabetes Association, is the premier clinical diabetes journal in the world. In order for new advances in the science of diabetes care to be accepted, there first needs to be research published in a leading scientific journal such as this. The editors of Diabetes Care take great care that these scientific articles are first judged by their manuscript reviewers, a carefully selected worldwide panel of diabetes experts. It is considered a great honor to be one of their reviewers.

03/11/2016 -